Effect of Mendelsohn Maneuver, Effortful Swallow Training, and the Shaker Exercise on Swallowing … (NCT07271888) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of Mendelsohn Maneuver, Effortful Swallow Training, and the Shaker Exercise on Swallowing Ability Among Dysphagic Patients With Cerebrovascular Accident
104 participantsStarted 2025-12-01
Plain-language summary
The study aims to Compare the effect of Mendelsohn maneuver, effortful swallow training, and the Shaker exercise on neurogenic dysphagia among stroke patients.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. An adult patient diagnosed with stroke.
. Patients who had been diagnosed with dysphagia after stroke.
. Patients who are hemodynamically stable, conscious and have adequate cognitive ability to follow simple instructions and able to sit upright for at least 30 minutes.
Exclusion criteria
. Unstable angina and myocardial infarction)MI(.
. History of seizure.
. Head injury or neurological disease other than stroke, neurosurgery .
. Oral and maxillofacial surgery.
. Dysphagia prior to stroke.
. Gastrointestinal tract upsets.
. Patients who receive hypnotics or sedation.
. critical ill.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Gugging swallowing screen
Timeframe: The data collection period 12 weeks
Trial details
NCT IDNCT07271888
SponsorUniversity of Baghdad
Sponsor typeOTHER
Study typeINTERVENTIONAL
Primary completion2026-02-28
Contact for this trial
Shahlaa Ali Talib Street address Wasit, Street 571 City Wasit Ali SAli, Latest degree Master